JNK and Macroautophagy Activation by Bortezomib Has a Pro-Survival Effect in Primary Effusion Lymphoma Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Granato, Marisa ^a   Santarelli, Roberta ^a   Lotti, Lavinia V ^a   Di Renzo, Livia ^a   Gonnella, Roberta ^a   Garufi, Alessia ^b   Trivedi, Pankaj ^a   Frati, Luigi ^a   D'Orazi, Gabriella ^b,c   Faggioni, Alberto ^a   Cirone, Mara ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 METHYLADENINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BAFILOMYCIN A1; BORTEZOMIB; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IFOSFAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PREDNISONE; STRESS ACTIVATED PROTEIN KINASE; VINCRISTINE;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL ACTIVATION; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; LYMPHOMA CELL; MACROAUTOPHAGY; MONOTHERAPY; NONHUMAN; PRIMARY EFFUSION LYMPHOMA; PROTEIN CLEAVAGE; UPREGULATION;

AUTOPHAGY; BLOTTING, WESTERN; BORONIC ACIDS; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYMPHOMA, PRIMARY EFFUSION; MAP KINASE KINASE 4; MICROSCOPY, ELECTRON; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRAZINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84884626755     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075965     Document Type: Article

References (42)

1. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, et al. (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88: 645-656.
2. Cirone M, Di Renzo L, Lotti LV, Conte V, Trivedi P, et al. (2012) Primary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91. PLoS One 7: e31732.
3. Matta H, Chaudhary PM, (2005) The proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells. Cancer Biol Ther 4: 77-82.
4. Chari A, Mazumder A, Jagannath S, (2010) Proteasome inhibition and its therapeutic potential in multiple myeloma. Biologics 4: 273-287.
5. Verfaillie T, Salazar M, Velasco G, Agostinis P, (2010) Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy. Int J Cell Biol 2010: 930509.
6. Kaufman RJ, Scheuner D, Schroder M, Shen X, Lee K, et al. (2002) The unfolded protein response in nutrient sensing and differentiation. Nat Rev Mol Cell Biol 3: 411-421.
7. Walter P, Ron D, (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334: 1081-1086.
8. Jager R, Bertrand MJ, Gorman AM, Vandenabeele P, Samali A, (2012) The unfolded protein response at the crossroads of cellular life and death during endoplasmic reticulum stress. Biol Cell 104: 259-270.
9. Trusina A, Tang C, (2010) The unfolded protein response and translation attenuation: a modelling approach. Diabetes Obes Metab 12Suppl 2: 27-31.
10. Tsai YC, Weissman AM, (2010) The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and Cancer. Genes Cancer 1: 764-778.
11. Tabas I, Ron D, (2011) Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 13: 184-190.
12. Milani M, Rzymski T, Mellor HR, Pike L, Bottini A, et al. (2009) The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res 69: 4415-4423.
13. Wu WK, Sakamoto KM, Milani M, Aldana-Masankgay G, Fan D, et al. (2010) Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy. Drug Resist Updat 13: 87-92.
14. Ding WX, Ni HM, Gao W, Hou YF, Melan MA, et al. (2007) Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J Biol Chem 282: 4702-4710.
15. Korolchuk VI, Menzies FM, Rubinsztein DC, (2010) Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett 584: 1393-1398.
16. Amaravadi RK, Thompson CB, (2007) The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res 13: 7271-7279.
17. Levine B, Klionsky DJ, (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463-477.
18. Tanida I, (2011) Autophagosome formation and molecular mechanism of autophagy. Antioxid Redox Signal 14: 2201-2214.
19. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728.
20. Tanida I, Minematsu-Ikeguchi N, Ueno T, Kominami E, (2005) Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 1: 84-91.
21. Kroemer G, Jaattela M, (2005) Lysosomes and autophagy in cell death control. Nat Rev Cancer 5: 886-897.
22. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, et al. (1998) Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 23: 33-42.
23. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, et al. (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171: 603-614.
24. Bjorkoy G, Lamark T, Pankiv S, Overvatn A, Brech A, et al. (2009) Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol 452: 181-197.
25. Li DD, Wang LL, Deng R, Tang J, Shen Y, et al. (2009) The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene 28: 886-898.
26. Li C, Johnson DE, (2012) Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation. Cancer Lett 314: 102-107.
27. Pattingre S, Bauvy C, Carpentier S, Levade T, Levine B, et al. (2009) Role of JNK1-dependent Bcl-2 phosphorylation in ceramide-induced macroautophagy. J Biol Chem 284: 2719-2728.
28. Hui B, Shi YH, Ding ZB, Zhou J, Gu CY, et al. (2012) Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma. Cancer 118: 5560-5571.
29. Kawaguchi T, Miyazawa K, Moriya S, Ohtomo T, Che XF, et al. (2011) Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress. Int J Oncol 38: 643-654.
30. Hoang B, Benavides A, Shi Y, Frost P, Lichtenstein A, (2009) Effect of autophagy on multiple myeloma cell viability. Mol Cancer Ther 8: 1974-1984.
31. Jenner RG, Maillard K, Cattini N, Weiss RA, Boshoff C, et al. (2003) Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Sci U S A 100: 10399-10404.
32. Puca R, Nardinocchi L, Starace G, Rechavi G, Sacchi A, et al. (2010) Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis. Free Radic Biol Med 48: 1338-1346.
33. Butterfield L, Storey B, Maas L, Heasley LE, (1997) c-Jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J Biol Chem 272: 10110-10116.
34. Obeng EA, Carlson LM, Gutman DM, Harrington WJ Jr, Lee KP, et al. (2006) Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 107: 4907-4916.
35. Wang M, Wey S, Zhang Y, Ye R, Lee AS, (2009) Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid Redox Signal 11: 2307-2316.
36. Benoit M, Dormond-Meuwly A, Demartines N, Dormond O, (2011) Targeting the JNK signaling pathway potentiates the antiproliferative efficacy of rapamycin in LS174T colon cancer cells. J Surg Res 167: e193-198.
37. Mizushima N, Yoshimori T, (2007) How to interpret LC3 immunoblotting. Autophagy 3: 542-545.
38. Johnston JA, Ward CL, Kopito RR, (1998) Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143: 1883-1898.
39. Wei J, Pattingre S, Sinha S, Bassik M, Levine B, (2008) JNK-mediated phosphorylation of Bcl-2 regulates starvation-induced atophagy. Mol Cell 30 (6): 678-688.
40. Puissant A, Robert G, Fenouille N, Luciano F, Cassuto JP, et al. (2010) Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res 70: 1042-1052.
41. Wu WK, Cho CH, Lee CW, Wu YC, Yu L, et al. (2010) Macroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cells. Autophagy 6: 228-238.
42. Yang Y, Ikezoe T, Saito T, Kobayashi M, Koeffler HP, et al. (2004) Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling. Cancer Sci 95: 176-180.